BioCentury
ARTICLE | Company News

Allozyne, Poniard deal

January 2, 2012 8:00 AM UTC

The companies mutually terminated their reverse merger after determining the stock of the combined company would not qualify for listing on NASDAQ, a condition for the close of the deal. Poniard said ...